WASHINGTON — FDA Commissioner Robert Califf appeared before the House Oversight Committee on Thursday to plead his case again for more authority to monitor the supply chain to prevent drug shortages.
Califf fielded a wide array of questions on issues ranging from lead in some applesauce pouches to Covid-19 vaccines to abortion drugs. But members of both sides of the aisle touched on drug shortages, which could see new legislative action as congressional hearings late last year pledged to help.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.